 |
|
|
 |
:: July 20, 2010
Scores for the June 2010 ACMO Examination have been posted online.
- View Now
|
 |
::July 20, 2010
Verification letters for the August 2010 Part I (ABS) and Part III (CSE) Examinations have been posted online.
- More Information
|
|
|
::July 07, 2010
Registration for the December 2010 Part II (PAM) and TMOD Examination is now available.
- Register Now
|
|
|
::May 05, 2010
National Board of Examiners in Optometry Places Hold on Part I Scores.
- More Information
|
|
|
::February 19, 2010
Candidates can now request official score reports be sent to The Alberta College of Optometrists and The College of Optometrists of British Columbia.
- Request Now
|
|
|
::January 07, 2010
State Law Exams are now administered online through the NBEO web site.
- View Now
|
|
|
|
|
 |
|
|
The Treatment and Management of Ocular Disease (TMOD) examination is no longer administered as a separate examination. TMOD will continue to be administered as an embedded subtest within the overall Part II - Patient Assessment and Management (PAM) examination. Even if a candidate is taking the Part II - PAM examination solely for the purpose of obtaining an embedded TMOD score, the entire Part II examination must be taken. However, candidates who desire a TMOD-only score may select this TMOD-only score option during registration.
Of the 350 items that comprise the PAM examination, 100 – 120 are categorized as TMOD (Treatment and Management of Ocular Disease) items. The TMOD breakout score and pass-fail decision will be determined based on these items, and reported for state boards requirements. In order to be classified as a TMOD item, the content of the item must pertain to one or more of the following:
- Formulation of most appropriate disease diagnosis which will be treated and/or managed
- Clinical correlation of basic science principles related to disease diagnosis and treatment
- Selection of treatment/management, including systemic considerations
- Dose, form, schedule, and duration of treatment
- Contraindications and side effects of medication, including systemic considerations
- Follow-up and prognosis, including reassessment of diagnosis after initiating treatment
- Treatment and management of ocular emergencies and urgencies
For more information regarding the Part II - PAM and the embedded TMOD examination, click here.
|
|
